This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Pfizer Corporation. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2022
Title: The Innovations of Fang Jin
Introduction
Fang Jin is an accomplished inventor based in Waban, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. With a total of 2 patents, his work has the potential to impact therapeutic and diagnostic methods.
Latest Patents
Fang Jin's latest patents include "Antibodies specific for CD3 and uses thereof." This invention provides novel antibodies that specifically bind to CD3, along with therapeutic and diagnostic methods utilizing these antibodies and their antigen-binding fragments. Another notable patent is "Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates," which discloses anti-IL-13-Rα2 antibodies and antibody-drug conjugates, along with methods for preparing and using them.
Career Highlights
Fang Jin is currently employed at Pfizer Corporation, where he continues to advance his research in antibody development. His work at Pfizer has allowed him to collaborate with leading experts in the field, enhancing the impact of his inventions.
Collaborations
Some of Fang Jin's notable coworkers include Lioudmila Tchistiakova and Dangshe Ma, who contribute to the innovative environment at Pfizer Corporation.
Conclusion
Fang Jin's contributions to biotechnology through his patents and work at Pfizer Corporation highlight his role as a significant inventor in the field. His innovative approaches to antibody development are paving the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile